{{Rsnum
|rsid=8177516
|Gene=SLC22A2
|Chromosome=6
|position=160243653
|Orientation=plus
|GMAF=0.002755
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=SLC22A2
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 100.0 | 0.0 | 0.0
| HCB | 97.8 | 2.2 | 0.0
| JPT | 100.0 | 0.0 | 0.0
| YRI | 97.3 | 2.7 | 0.0
| ASW | 96.5 | 3.5 | 0.0
| CHB | 97.8 | 2.2 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 99.1 | 0.9 | 0.0
| MEX | 98.3 | 1.7 | 0.0
| MKK | 99.4 | 0.6 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs8177516
|Name_s=SLC22A2: R400C
|Gene_s=SLC22A2
|Feature=Exon/NonSyn
|Evidence=PubMed ID:19940846
|Annotation=Increased sensitivity to inhibition by TBA in oocytes
|Drugs=
|Drug Classes=
|Diseases=
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA165111565
}}

{{GET Evidence
|gene=SLC22A2
|aa_change=Arg400Cys
|aa_change_short=R400C
|impact=not reviewed
|qualified_impact=Insufficiently evaluated not reviewed
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs8177516
|overall_frequency_n=54
|overall_frequency_d=10758
|overall_frequency=0.00501952
|n_genomes=1
|n_genomes_annotated=0
|n_haplomes=1
|n_articles=0
|n_articles_annotated=0
|pph2_score=0.81
|nblosum100=8
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}